 LOS ANGELES, July 12, 2021 GLOBE NEWSWIRE -- NASDAQ: ENOB Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the FDA has accepted a Pre-IND Investigational New Drug request for a potential cure of hepatitis B virus HBV infection. Written comments are expected this Fall. 